Latest in Investment Twitter

Sort by

204 items

Cannabis stock valuations and investments hobbled by regulatory uncertainties, experts say

A reality check around regulatory challenges facing the cannabis sector has taken hold among some of the leading financiers in the industry, as optimism around the promise of a legal market has faded.
Business - MarketWatch - November 12
RWE scales back €55bn renewables bet after Trump win

German power producer was already under pressure from shareholders to lift returns
World - Financial Times - November 13
Healthy Returns: AstraZeneca expands U.S. investment plan on confidence in economy

AstraZeneca said it is doubling down on its investment in its U.S. business. Meanwhile, General Catalyst has agreed to purchase Summa Health for $485 million.
Business - CNBC - November 13

Cannabis stock valuations and investments hobbled by regulatory uncertainties, experts say